B. Metzler seel. Sohn & Co. AG Has $3.64 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

B. Metzler seel. Sohn & Co. AG increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 13.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,123 shares of the biotechnology company’s stock after buying an additional 713 shares during the quarter. B. Metzler seel. Sohn & Co. AG’s holdings in Axon Enterprise were worth $3,639,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in AXON. Asset Dedication LLC raised its stake in shares of Axon Enterprise by 11.3% during the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares during the last quarter. Bleakley Financial Group LLC increased its holdings in Axon Enterprise by 1.3% in the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC raised its position in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after purchasing an additional 21 shares during the last quarter. Insigneo Advisory Services LLC lifted its holdings in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares during the period. Finally, Menard Financial Group LLC grew its position in shares of Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on AXON. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Needham & Company LLC restated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Axon Enterprise Trading Up 2.9 %

NASDAQ AXON opened at $541.20 on Wednesday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The business has a 50 day moving average price of $586.98 and a 200-day moving average price of $552.75. The company has a market cap of $41.47 billion, a price-to-earnings ratio of 139.85, a P/E/G ratio of 5.17 and a beta of 1.12.

Insider Buying and Selling at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.